FutureTech II Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FTII research report →
Price Chart
About the company
FutureTech II Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
- CEO
- Ray Chen
- IPO
- 2022
- Employees
- 1
- HQ
- New Rochelle, NY, US
Get TickerSpark's AI analysis on FTII
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $51.57M
- P/E
- -41.45
- PEG
- 0.16
- P/S
- 0.00
- P/B
- 134.89
- EV/EBITDA
- 0.00
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -2.60%
- ROIC
- 0.00%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $0
- Net Income
- $-747,000-125.7%
- EPS
- $-0.29-226.1%
- OCF Growth
- -9.0%
- FCF Growth
- -9.0%
- 52W High
- $14.00
- 52W Low
- $10.52
- 50D MA
- $12.02
- 200D MA
- $11.93
- Beta
- -0.02
- RSI (14)
- 0
- Avg Volume
- 242
No earnings-call transcripts are available for FTII yet.
- Free Float
- 33.0%
- Shares Outstanding
- 4.29M
- Float Shares
- 1.41M
of shares held by institutions
12 13F filers
Buy/sell ratio 1.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Cowen And Company, LLC | 121.98K | ▲ 1.49K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 4, 25 | Chen Ray Lei | other | 380,000 |
| Feb 4, 25 | Chen Ray Lei | other | 380,000 |
| Feb 4, 25 | Radu Zachary C. | other | 2,445,000 |
| Feb 4, 25 | Radu Zachary C. | other | 2,445,000 |
| Feb 4, 25 | Bush Neil | other | 10,000 |
| Feb 4, 25 | Bush Neil | other | 10,000 |
| Feb 4, 25 | Moseley Jeffrey Alan | other | 10,000 |
| Feb 4, 25 | Moseley Jeffrey Alan | other | 10,000 |
| Feb 4, 25 | Zutshi Aroop | other | 10,000 |
| Feb 4, 25 | Zutshi Aroop | other | 10,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our FTII coverage
Recent articles, reports, and earnings notes.
No research on FTII yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FTII report →FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance
globenewswire.com · Dec 4
Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity
globenewswire.com · Sep 20
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.